Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCT
Conditions: Allogeneic Hematopoietic Stem Cell Transplantation; Acute Lymphoblastic Leukemia Intervention: Drug: VEN+AZA+Modified BUCY Sponsor: The First Affiliated Hospital of Soochow University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Hospitals | Leukemia | Research | Stem Cell Therapy | Stem Cells | Transplants